NCT06428175

Brief Summary

Aim 1: Compare the effectiveness of focused dose vs extended dose hospital-to-home Transitional Care Interventions (H2H-TCI) on health service use and parent-reported confidence for hospitalized CYSHCN. Aim 2: Compare the effectiveness of focused and extended dose H2H-TCI among vulnerable CYSHCN subgroups. Hypothesis: Both H2H-TCI arms will improve primary outcomes more for CYSHCN with higher versus lower clinical complexity; while extended H2H-TCI will better mitigate racial/ethnic outcome disparities than focused H2H-TCI. Aim 3: Evaluate implementation context, processes, and mechanisms via a multi-phase mixed methods study design.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for not_applicable

Timeline
34mo left

Started Aug 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Aug 2025Feb 2029

First Submitted

Initial submission to the registry

May 20, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 24, 2024

Completed
1.3 years until next milestone

Study Start

First participant enrolled

August 28, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

2.9 years

First QC Date

May 20, 2024

Last Update Submit

September 5, 2025

Conditions

Keywords

Special NeedsHospital to Home CareChildren and Youth with Special Health Care NeedsRandomized Trial

Outcome Measures

Primary Outcomes (2)

  • 30-day acute care use

    30-day, all-cause composite readmission and emergency department (ED) visit rate

    30 days post-hospital discharge

  • Caregiver confidence

    Change in caregiver-reported confidence that their child can avoid hospitalization within the next one month (1=not confident; 10=fully confident; \<5 is low confidence)

    Baseline, 30 days post-discharge

Secondary Outcomes (12)

  • 7-day acute care use

    7-days post-discharge

  • 14-day acute care use

    14 days post-discharge

  • Readmissions

    7, 14, 30 days post-discharge

  • Emergency Department (ED) visits

    7, 14, 30 days post-discharge

  • Outpatient follow-up visit attendance

    7, 14, 30 days post-discharge

  • +7 more secondary outcomes

Study Arms (2)

Focused Dose Hospital-to-Home Transitional Care Interventions

ACTIVE COMPARATOR
Behavioral: Focused Dose Hospital-to-Home Transitional Care Interventions

Extended Dose Hospital-to-Home Transitional Care Interventions

ACTIVE COMPARATOR
Behavioral: Extended Dose Hospital-to-Home Transitional Care Interventions

Interventions

Focused dose H2H-TCIs will consist of a one-time post-discharge phone call completed within 72 hours post-hospital discharge by a clinical interventionist (e.g., nurse care coordinator or care manager). Calls will follow a structured template that provides empirically supported core H2H-TCI functions (follow-up care access, contingency planning, medication review, family education). The interventionist will also conduct a pre-hospital discharge clinical needs assessment with the parent.

Focused Dose Hospital-to-Home Transitional Care Interventions

Extended dose H2H-TCIs will include a pre-discharge clinical needs assessment and initial phone call within 72 hours post-discharge, similar to the focused arm. After the initial contact, the dose of the extended H2H-TCI will increase as subjects receive high-intensity support during weekly post-discharge phone contacts through 30 days post-discharge. All contacts in the extended dose arm will be completed by a transition coach interventionist (e.g., nurse care coordinator or care manager) who will be formally trained on pillars of the Care Transitions Intervention© (CTI), a multi-faceted H2H-TCI that is the basis for the extended dose arm.

Extended Dose Hospital-to-Home Transitional Care Interventions

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Child is a CYSHCN, defined as having seen two or more distinct specialty areas for outpatient visits during the 12 months prior to index hospitalization admission date
  • Age of hospitalized child is under 18 years old
  • Child hospitalized on a general pediatrics inpatient service line at participating site
  • Adult parent/caregiver for the child is 18 years or older

You may not qualify if:

  • Child will be discharged to any location besides home (e.g., long-term care or residential facility, skilled nursing facility, inpatient acute rehabilitation, psychiatric facility)
  • Child is a ward of the state or has an ongoing social services investigation
  • Child is already receiving transitional care, intensive longitudinal care coordination (e.g., organ/disease-specific clinical program, clinical division within the same institution as the hospital \[e.g., Children's Complex Care Program at UNC; Complex Care Service at Duke\]), and/or longitudinal population health care coordination as part of a bundled alternative payment care model.
  • Age less than 18 years old
  • Diminished capacity to provide consent/participate
  • Primary language for parent/caregiver is any language besides English or Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UNC Hospitals

Chapel Hill, North Carolina, 27514, United States

RECRUITING

DUHS

Durham, North Carolina, 27701, United States

RECRUITING

Study Officials

  • David Ming, MD

    Duke University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jennifer Thomas, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2024

First Posted

May 24, 2024

Study Start

August 28, 2025

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

February 1, 2029

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations